金沙登录平台入口


Latest results announcements and presentations金沙app


金沙登录平台入口


Capital markets event - Meet AZN management: ASCO 2020金沙登录平台入口

1 June 2020

Opening session

MP3

Tagrisso and immuno-oncology

MP3

Enhertu and breast cancer

MP3

Lynparza

MP3

Calquence and haematology

MP3


First-quarter 2020 results金沙登录平台入口

29 April 2020


Full-year and Q4 2019 results金沙登录平台入口

14 February 2020


Epidemiology data update金沙登录平台入口

14 February 2020

金沙登录平台入口


General investor presentation金沙登录平台入口

24 December 2019


Investor science conference call: American Society of Hematology 2019金沙登录平台入口

10 December 2019

Investor conference science conference call – ASH 2019 audio replay

MP3


Investor science conference call: American College of Rheumatology 2019金沙登录平台入口

13 November 2019

Investor science conference call - ACR 2019 audio replay

MP3


Investor science conference call: American Society of Nephrology Kidney Week 2019金沙登录平台入口

11 November 2019

Investor science conference call - ASN 2019 audio replay

MP3


Year-to-date and Q3 2019 Results金沙登录平台入口

24 October 2019


Investor science conference call: European Society for Medical Oncology (ESMO) Congress 2019金沙登录平台入口

30 September 2019


Investor science conference call: Farxiga's DAPA-HF trial at ESC 2019金沙登录平台入口

1 September 2019


H1 2019 Results金沙登录平台入口

25 July 2019


‘Meet AZN management’ at 2019 ASCO Annual Meeting金沙登录平台入口

3 June 2019


Q1 2019 Results金沙登录平台入口

26 April 2019


Collaboration on trastuzumab deruxtecan Investor conference call金沙登录平台入口

29 March 2019


Full-Year 2018 Results金沙登录平台入口

14 February 2019

金沙登录平台入口


Year-end webcast for investors and analysts on China and Emerging Markets金沙登录平台入口

13 December 2018

Year-End Investor & Analyst Webcast, China and Emerging Markets video

Video


AHA Scientific Sessions 2018金沙登录平台入口

12 November 2018


Year-To-Date and Q3 2018 Results金沙登录平台入口

8 November 2018


H1 2018 Results金沙登录平台入口

26 July 2018


AstraZeneca Investor Event at the 2018 ASCO Annual Meeting金沙登录平台入口

1 June 2018


Q1 2018 Results金沙登录平台入口

18 May 2018


Full-Year 2017 Results金沙登录平台入口

2 February 2018


金沙登录平台入口


Investor science event: Late-stage pipeline webcast金沙登录平台入口

14 December 2017


Year-To-Date and Q3 2017 Results金沙登录平台入口

9 November 2017


AstraZeneca Investor Science Event at ERS 2017金沙登录平台入口

13 September 2017


AstraZeneca Investor Science Event at ESMO 2017金沙登录平台入口

8 September 2017


H1 2017 Results金沙登录平台入口

27 July 2017


General Investor presentation金沙登录平台入口

16 June 2017


AstraZeneca Investor Science Event at 2017 ASCO Annual Meeting金沙登录平台入口

5 June 2017


Q1 2017 Results金沙登录平台入口

27 April 2017


Full-Year and Q4 2016 Results金沙登录平台入口

2 February 2017


金沙登录平台入口


Second year-end late-stage pipeline investor science webcast金沙登录平台入口

15 December 2016


Year-to-date and Q3 2016 Results金沙登录平台入口

10 November 2016


Investor Relations Benelux roadshow金沙登录平台入口

8 September 2016


ERS Investor science webcast金沙登录平台入口

7 September 2016


DNA Damage Response analyst science event金沙登录平台入口

5 September 2016


H1 2016 Results金沙登录平台入口

28 July 2016


AstraZeneca Investor Science Event at ASCO 2016金沙登录平台入口

7 June 2016


Q1 2016 Results金沙登录平台入口

29 April 2016


Full-Year and Q4 2015 Results金沙登录平台入口

4 February 2016


J.P. Morgan Healthcare Conference 2016金沙登录平台入口

13 January 2016


金沙登录平台入口


Majority stake investment in Acerta Pharma金沙登录平台入口

17 December 2015


Late-stage pipeline call金沙登录平台入口

2 December 2015


American College of Rheumatology (ACR) 2015 Investor science conference call金沙登录平台入口

11 November 2015


Acquisition of ZS Pharma金沙登录平台入口

6 November 2015


Year-to-date and Q3 2015 results金沙登录平台入口

5 November 2015


H1 2015 results金沙登录平台入口

30 July 2015


American Society of Clinical Oncology (ASCO) 2015 Investor science event金沙登录平台入口

1 June 2015


AstraZeneca Mölndal 金沙登录平台入口

25 May 2015


First quarter results 2015 金沙登录平台入口

24 April 2015


American College of Cardiology (ACC) 2015 Investor science conference call金沙登录平台入口

16 March 2015


Fourth quarter and full year results 2014金沙登录平台入口

5 February 2015


33rd J.P. Morgan Healthcare Conference金沙登录平台入口

14 January 2015


金沙登录平台入口


AstraZeneca Investor Day金沙登录平台入口

18 November 2014


Third quarter and nine months results 2014 金沙登录平台入口

6 November 2014


European Society for Medical Oncology (ESMO) 2014 金沙登录平台入口

28 September 2014


Second quarter and half year results 2014 金沙登录平台入口

31 July 2014


Strategic Transaction with Almirall in Respiratory Disease金沙登录平台入口

30 July 2014


American Society of Clinical Oncology (ASCO) 2014金沙登录平台入口

3 June 2014


American Thoracic Society (ATS) 2014 AstraZeneca Analyst briefing金沙登录平台入口

20 May 2014


AstraZeneca strategy update 金沙登录平台入口

6 May 2014


First quarter results 2014 金沙登录平台入口

24 April 2014


Fourth quarter and full year Results 2013 金沙登录平台入口

6 February 2014


J.P. Morgan Healthcare conference presentation金沙登录平台入口

14 January 2014


金沙登录平台入口


Global diabetes alliance analyst call 金沙登录平台入口

19 December 2013


MedImmune R&D Roadshow 金沙登录平台入口

7 November 2013


Third quarter and nine months results 2013 金沙登录平台入口

31 October 2013


Second quarter and half year results 2013 金沙登录平台入口

1 August 2013


American Society of Clinical Oncology (ASCO) 2013 briefing 金沙登录平台入口

1 June 2013


First quarter results 2013金沙登录平台入口

25 April 2013


AstraZeneca Investor Day金沙登录平台入口

21 March 2013


Fourth quarter and full year results 2012金沙登录平台入口

31 January 2013


Partnering for Growth: J.P. Morgan Healthcare Conference金沙登录平台入口

9 January 2013


金沙登录平台入口


Fostamatinib analyst briefing金沙登录平台入口

15 November 2012

Fostamatinib analyst briefing video

Play Video


Third quarter and nine months results 2012金沙登录平台入口

25 October 2012


Naloxegol educational presentation金沙登录平台入口

18 October 2012

Naloxegol educational presentation video

Play Video


Second quarter and half year results 2012金沙登录平台入口

26 July 2012


AstraZeneca business update金沙登录平台入口

2 July 2012


R&D Roundtable金沙登录平台入口

14 June 2012


First quarter results 2012金沙登录平台入口

26 April 2012


Fourth quarter and full year results 2011金沙登录平台入口

2 February 2012


30th Annual J.P. Morgan Healthcare Conference金沙登录平台入口

11 January 2012


Upcoming events金沙app

J.P. Morgan European Healthcare Conference [Management] 金沙登录平台入口

H1 2020 Results金沙登录平台入口


SEC filings金沙app

SEC filings are those documents that we are required to file by virtue of our listing on the New York Stock Exchange. They contain mainly financial 资讯rmation.

These documents are also available for viewing on the SEC website at www.sec.gov. The Company will send any holder of the Company’s securities, upon request, a hard copy of the Company’s complete audited financial statements free of charge. Requests may be made by writing to:

Company Secretary
AstraZeneca PLC
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA



金沙app

 

金沙登录平台入口


金沙app

金沙登录平台入口

金沙手机app平台

Thomas Kudsk Larsen

金沙官网

Henry Wheeler

Oncology

澳门金沙平台官网

Josie Afolabi

BioPharmaceuticals (Respiratory & Immunology)

金沙网站

Craig Marks

Finance, fixed income

金沙官网金沙注册金沙平台

Christer Gruvris

BioPharmaceuticals (CV, Metabolism)

金沙平台

Tom Waldron

Other medicines

金沙手机app平台

Jennifer Kretzmann

Corporate access, retail investors

金沙正规娱乐官网

Nick Stone

BioPharmaceuticals (Renal), ESG

US general enquiries